|3D model (Jmol)||Interactive image|
|Molar mass||457.838 g/mol|
|Appearance||White powder, hygroscopic|
|Solubility||soluble in acids|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|what is ?)(|
Lanthanum carbonate is used as a starting material in lanthanum chemistry, particularly in forming mixed oxides, for example
- for production of lanthanum strontium manganite, primarily for solid oxide fuel cell applications;
- for production of certain high-temperature superconductors, such as La2-xSrxCuO2.
Lanthanum carbonate is used in medicine as a phosphate binder. As a medication it is sold under the trade name Fosrenol by the pharmaceutical company Shire Pharmaceuticals. Due to its large size (1000mg tablet is 2.2cm in diameter), it may be possible to choke on the tablet if it is not chewed. It is prescribed for the treatment of hyperphosphatemia, primarily in patients with chronic kidney disease. It is taken with meals and binds to dietary phosphate, preventing phosphate from being absorbed by the intestine. For cats suffering from hyperphosphatemia it is available under the trade name Renalzin by Bayer Animal Health.
However, when lanthanum carbonate is used for treating hyperphosphatemia, its side effects, namely myalgia, muscular cramping, and peripheral edema, should be clinically monitored.
- Editorial Staff (December 2004). "Lanthanum Carbonate". All Micromedex Systems. Micromedex, Inc. Archived from the original on 2007-09-14. Retrieved 2007-11-25.
- Bayer Animal Health (26 September 2008). "Bayer Animal Health launches Renalzin for Cats" (PDF). Retrieved 2008-09-30.
- Tonelli, Marcello; Pannu, Neesh; Manns, Braden (2010). "Oral Phosphate Binders in Patients with Kidney Failure". New England Journal of Medicine. 362 (14): 1312. doi:10.1056/NEJMra0912522. PMID 20375408.